BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8248934)

  • 1. Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro.
    Kedderis GL; Carfagna MA; Held SD; Batra R; Murphy JE; Gargas ML
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):274-82. PubMed ID: 8248934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats, mice, and humans.
    Kedderis GL; Held SD
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):124-30. PubMed ID: 8806878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Furan-induced cytolethality in isolated rat hepatocytes: correspondence with in vivo dosimetry.
    Carfagna MA; Held SD; Kedderis GL
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):265-73. PubMed ID: 8248933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furan-mediated uncoupling of hepatic oxidative phosphorylation in Fischer-344 rats: an early event in cell death.
    Mugford CA; Carfagna MA; Kedderis GL
    Toxicol Appl Pharmacol; 1997 May; 144(1):1-11. PubMed ID: 9169064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and metabolism of vinyl fluoride in vivo and in vitro.
    Cantoreggi S; Keller DA
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):130-9. PubMed ID: 9073601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats.
    Evans MV; Crank WD; Yang HM; Simmons JE
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):36-44. PubMed ID: 8079352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).
    Loizou GD; Anders MW
    Drug Metab Dispos; 1993; 21(4):634-9. PubMed ID: 8104122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically based pharmacokinetic estimated metabolic constants and hepatotoxicity of carbon tetrachloride after methanol pretreatment in rats.
    Evans MV; Simmons JE
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):245-53. PubMed ID: 8887440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
    Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
    J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).
    Loizou GD; Urban G; Dekant W; Anders MW
    Drug Metab Dispos; 1994; 22(4):511-7. PubMed ID: 7956723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a physiologically based pharmacokinetic model for chlorobenzene in F-344 rats.
    Thrall KD; Woodstock AD; Kania MR
    J Toxicol Environ Health A; 2004 Apr; 67(7):525-36. PubMed ID: 15129550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroform-induced cytolethality in freshly isolated male B6C3F1 mouse and F-344 rat hepatocytes.
    Ammann P; Laethem CL; Kedderis GL
    Toxicol Appl Pharmacol; 1998 Apr; 149(2):217-25. PubMed ID: 9571991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gas-liquid system for enzyme kinetic studies of volatile organic chemicals. Determination of enzyme kinetic constants and partition coefficients of trichloroethylene.
    Hwang IY; Reardon KF; Tessari JD; Yang RS
    Drug Metab Dispos; 1996 Apr; 24(4):377-82. PubMed ID: 8801050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas uptake studies of deuterium isotope effects on dichloromethane metabolism in female B6C3F1 mice in vivo.
    Andersen ME; Clewell HJ; Mahle DA; Gearhart JM
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):158-65. PubMed ID: 8079349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans.
    Pastino GM; Asgharian B; Roberts K; Medinsky MA; Bond JA
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):147-57. PubMed ID: 9221833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a physiologically based pharmacokinetic model for methyl ethyl ketone in F344 rats.
    Thrall KD; Soelberg JJ; Weitz KK; Woodstock AD
    J Toxicol Environ Health A; 2002 Jul; 65(13):881-96. PubMed ID: 12133235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of physiologically based pharmacokinetic model for methyl tertiary-butyl ether and tertiary-butanol in male Fisher-344 rats.
    Borghoff SJ; Murphy JE; Medinsky MA
    Fundam Appl Toxicol; 1996 Apr; 30(2):264-75. PubMed ID: 8812274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione trapping to measure microsomal oxidation of furan to cis-2-butene-1,4-dial.
    Peterson LA; Cummings ME; Vu CC; Matter BA
    Drug Metab Dispos; 2005 Oct; 33(10):1453-8. PubMed ID: 16006568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.